Cargando…
In vivo silencing of alpha-synuclein using naked siRNA
BACKGROUND: Overexpression of α-synuclein (SNCA) in families with multiplication mutations causes parkinsonism and subsequent dementia, characterized by diffuse Lewy Body disease post-mortem. Genetic variability in SNCA contributes to risk of idiopathic Parkinson's disease (PD), possibly as a r...
Autores principales: | Lewis, Jada, Melrose, Heather, Bumcrot, David, Hope, Andrew, Zehr, Cynthia, Lincoln, Sarah, Braithwaite, Adam, He, Zhen, Ogholikhan, Sina, Hinkle, Kelly, Kent, Caroline, Toudjarska, Ivanka, Charisse, Klaus, Braich, Ravi, Pandey, Rajendra K, Heckman, Michael, Maraganore, Demetrius M, Crook, Julia, Farrer, Matthew J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612658/ https://www.ncbi.nlm.nih.gov/pubmed/18976489 http://dx.doi.org/10.1186/1750-1326-3-19 |
Ejemplares similares
-
Rationale for Therapeutic Silencing of Alpha-Synuclein in Parkinson’s Disease
por: Maraganore, Demetrius M.
Publicado: (2011) -
α-Synuclein Suppression by Targeted Small Interfering RNA in the Primate Substantia Nigra
por: McCormack, Alison L., et al.
Publicado: (2010) -
Hepatitis Vaccines
por: Ogholikhan, Sina, et al.
Publicado: (2016) -
Leucine-rich repeat kinase 2 (LRRK2) regulates α-synuclein clearance in microglia
por: Maekawa, Tatsunori, et al.
Publicado: (2016) -
Interfering with disease: a progress report on siRNA-based therapeutics
por: de Fougerolles, Antonin, et al.
Publicado: (2007)